FDA Would Like to Join You in the Sandbox When Developing AI Enabled Devices
FDA Law Blog: Biosimilars
MARCH 6, 2025
Both guidance documents recommend data management practices for collecting data for use in developing, tuning, and testing an artificial intelligence model and making changes to said model.
Let's personalize your content